Experienced in Migraine with Brainstem Aura

Dr. Harshavardhan R. Krishna

Internal Medicine
Health First Medical Center Plc
12100 Dix Toledo Rd, 
Southgate, MI 
Accepting New Patients
Experienced in Migraine with Brainstem Aura
Health First Medical Center Plc
12100 Dix Toledo Rd, 
Southgate, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Harshavardhan Krishna is a primary care provider, practicing in Internal Medicine in Southgate, Michigan. Dr. Krishna is rated as an Experienced provider by MediFind in the treatment of Migraine with Brainstem Aura. His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Sitosterolemia, and Opioid Induced Constipation. Dr. Krishna is currently accepting new patients.

His clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in MI
Hospital Affiliations
Wyandotte Hospital And Medical Center
Languages Spoken
English
Hindi
Telugu
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

HEALTH FIRST MEDICAL CENTER PLC
12100 Dix Toledo Rd, Southgate, MI 48195

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Advanced in Migraine with Brainstem Aura
Dr. Lisa B. Elconin
Internal Medicine
Advanced in Migraine with Brainstem Aura
Dr. Lisa B. Elconin
Internal Medicine

Michigan Healthcare Professionals PC

5777 W Maple Rd, Suite 140, 
West Bloomfield, MI 
 (23.9 miles away)
248-406-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lisa Elconin is a primary care provider, practicing in Internal Medicine in West Bloomfield, Michigan. Dr. Elconin is rated as an Advanced provider by MediFind in the treatment of Migraine with Brainstem Aura. Her top areas of expertise are Juvenile Primary Osteoporosis, Sitosterolemia, Melorheostosis, and Melorheostosis with Osteopoikilosis. Dr. Elconin is currently accepting new patients.

Advanced in Migraine with Brainstem Aura
Dr. Fadi I. Oska
Internal Medicine
Advanced in Migraine with Brainstem Aura
Dr. Fadi I. Oska
Internal Medicine

Associates In Family Practice PLLC

42755 Mound Rd, 
Sterling Heights, MI 
 (27.7 miles away)
586-323-0400
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients
Offers Telehealth

Fadi Oska is a primary care provider, practicing in Internal Medicine in Sterling Heights, Michigan. Dr. Oska is rated as a Distinguished provider by MediFind in the treatment of Migraine with Brainstem Aura. His top areas of expertise are Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertension, Endoscopy, and Colonoscopy. Dr. Oska is currently accepting new patients.

Advanced in Migraine with Brainstem Aura
Dr. Eyas Kanaan
Internal Medicine
Advanced in Migraine with Brainstem Aura
Dr. Eyas Kanaan
Internal Medicine

Exclusive Physicians PLLC

4420 E Davison St, 
Detroit, MI 
 (15.3 miles away)
313-369-1500
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Eyas Kanaan is a primary care provider, practicing in Internal Medicine in Detroit, Michigan. Dr. Kanaan has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Migraine with Brainstem Aura. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Obesity, High Cholesterol, Endoscopy, and Gastrostomy. Dr. Kanaan is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Krishna's expertise for a condition
ConditionClose
        View All 19 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile